Position in FTRE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,124,540
+$974,358 QoQ
Shares Held
122,100
0.0% QoQ
Ownership
0.128%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#79
of 334 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FTRE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ING GROEP NV holds $202,433,197 across 10 Biotechnology names. FTRE ranks #9 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
223,124 | $110,832,384 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
32,086 | $20,006,904 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
564,600 | $19,981,194 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
103,000 | $19,289,840 | |
| 5 | EXEL |
Exelixis, Inc.
|
311,400 | $16,943,274 | |
| 6 | NKTR |
Nektar Therapeutics
|
100,000 | $6,981,000 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
12,244 | $2,950,436 | |
| 8 | INCY |
Incyte Corp
|
20,633 | $2,338,956 |
All Filings in FTRE
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,124,540 | 122,100 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $1,150,182 | 122,100 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $2,106,225 | 122,100 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $2,004,802 | 238,100 | Shares | Defined | 2025-11-06 | |
| 2025-06-30 | $1,176,214 | 238,100 | Shares | Defined | 2025-08-06 | |
| No filing history on record for this holder in this stock. | ||||||